Walleye Capital
IONS icon

Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Walleye Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Buy
17,400
+7,500
+76% +$592K 0.01% 1836
2025
Q4 		$783K Buy
9,900
+4,900
+98% +$369K ﹤0.01% 2630
2025
Q3 		$327K Sell
5,000
-5,700
-53% -$278K ﹤0.01% 2943
2025
Q2 		$423K Sell
10,700
-2,900
-21% -$94.9K ﹤0.01% 2776
2025
Q1 		$410K Sell
13,600
-1,300
-9% -$42.6K ﹤0.01% 2722
2024
Q4 		$521K Sell
14,900
-5,400
-27% -$202K ﹤0.01% 2941
2024
Q3 		$813K Sell
20,300
-7,300
-26% -$340K ﹤0.01% 2850
2024
Q2 		$1.32M Buy
27,600
+27,300
+9,100% +$1.12M ﹤0.01% 2553
2024
Q1 		$13K Hold
300
– – ﹤0.01% 5018
2023
Q4 		$15.2K Sell
300
-5,800
-95% -$278K ﹤0.01% 4510
2023
Q3 		$277K Buy
6,100
+5,700
+1,425% +$235K ﹤0.01% 3298
2023
Q2 		$16.4K Sell
400
-9,000
-96% -$346K ﹤0.01% 3839
2023
Q1 		$336K Buy
9,400
+5,900
+169% +$222K 0.01% 2033
2022
Q4 		$132K Buy
+3,500
New +$147K ﹤0.01% 2258
2020
Q1 		– Sell
-8,100
Closed -$489K – 1282
2019
Q4 		$489K Sell
8,100
-6,300
-44% -$375K 0.03% 675
2019
Q3 		$863K Buy
14,400
+1,700
+13% +$111K 0.05% 504
2019
Q2 		$816K Buy
12,700
+10,200
+408% +$721K 0.09% 331
2019
Q1 		$203K Buy
+2,500
New +$161K 0.03% 776

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's IONS Position: Q1 2026 in Review

Walleye Capital increased its Ionis Pharmaceuticals (IONS) stake by 20,192% in Q1 2026, buying an estimated $5.18M and bringing the position to 65,949 shares worth $4.95M. The position accounts for 0.02% of the portfolio, ranked #809.

Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 15 quarters since. The position peaked at $4.97M in Q3 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Walleye Capital held 65,949 shares of Ionis Pharmaceuticals worth $4.95M as of Q1 2026.
  • Walleye Capital bought 65,624 Ionis Pharmaceuticals shares in Q1 2026, an estimated $5.18M.
  • Ionis Pharmaceuticals made up 0.02% of Walleye Capital's portfolio in Q1 2026, its #809 holding.
  • Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.